HomeAll ContractsContract
SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING
Total Committed
$5.44M
Product or Service Description
Laboratory Testing
Total Potential Value
$5.44M
Effective Date
Dec. 29, 2020
Funding Department
CDC OFFICE OF ACQUISITION SERVICES
Type
Firm fixed price
Solicitation Procedure
Simplified acquisition
Extent Competed
Not competed under sap
Reason
Sap Non Competition (Far 13)

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
LABORATORY CORPORATION OF AMERICA SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING Feb. 8, 2021 Other Administrative Action $0
LABORATORY CORPORATION OF AMERICA SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING Jan. 22, 2021 Supplemental Agreement For Work Within Scope $3,865,000
LABORATORY CORPORATION OF AMERICA SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING Dec. 29, 2020 $1,575,000
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page